Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 57

1.

Ongoing and Focused Provider Performance Evaluations in Emergency Medicine: Current Practices and Modified Delphi to Guide Future Practice.

Walker LE, Phelan MP, Bitner M, Legome E, Tomaszewski CA, Strauss RW Jr, Nestler DM.

Am J Med Qual. 2019 Sep 13:1062860619874113. doi: 10.1177/1062860619874113. [Epub ahead of print]

PMID:
31516026
2.

Progression of Stargardt Disease as Determined by Fundus Autofluorescence Over a 12-Month Period: ProgStar Report No. 11.

Strauss RW, Kong X, Ho A, Jha A, West S, Ip M, Bernstein PS, Birch DG, Cideciyan AV, Michaelides M, Sahel JA, Sunness JS, Traboulsi EI, Zrenner E, Pitetta S, Jenkins D, Hariri AH, Sadda S, Scholl HPN; ProgStar Study Group.

JAMA Ophthalmol. 2019 Aug 1. doi: 10.1001/jamaophthalmol.2019.2885. [Epub ahead of print]

PMID:
31369039
3.

Reproducibility of Measurements of Retinal Structural Parameters Using Optical Coherence Tomography in Stargardt Disease.

Kong X, Ho A, Munoz B, West S, Strauss RW, Jha A, Ervin A, Buzas J, Singh M, Hu Z, Cheetham J, Ip M, Scholl HPN.

Transl Vis Sci Technol. 2019 Jun 21;8(3):46. doi: 10.1167/tvst.8.3.46. eCollection 2019 May.

4.

A Workshop on Measuring the Progression of Atrophy Secondary to Stargardt Disease in the ProgStar Studies: Findings and Lessons Learned.

Ervin AM, Strauss RW, Ahmed MI, Birch D, Cheetham J, Ferris FL 3rd, Ip MS, Jaffe GJ, Maguire MG, Schönbach EM, Sadda SR, West SK, Scholl HPN; ProgStar Study Group.

Transl Vis Sci Technol. 2019 Apr 12;8(2):16. doi: 10.1167/tvst.8.2.16. eCollection 2019 Apr.

5.

Cross-Sectional and Longitudinal Assessment of the Ellipsoid Zone in Childhood-Onset Stargardt Disease.

Tanna P, Georgiou M, Strauss RW, Ali N, Kumaran N, Kalitzeos A, Fujinami K, Michaelides M.

Transl Vis Sci Technol. 2019 Mar 1;8(2):1. doi: 10.1167/tvst.8.2.1. eCollection 2019 Mar.

6.

Impact of segmentation density on spectral domain optical coherence tomography assessment in Stargardt disease.

Velaga SB, Nittala MG, Jenkins D, Melendez J, Ho A, Strauss RW, Scholl HP, Sadda SR.

Graefes Arch Clin Exp Ophthalmol. 2019 Mar;257(3):549-556. doi: 10.1007/s00417-018-04229-3. Epub 2019 Jan 6.

PMID:
30613916
7.

Cross-Sectional and Longitudinal Assessment of Retinal Sensitivity in Patients With Childhood-Onset Stargardt Disease.

Tanna P, Georgiou M, Aboshiha J, Strauss RW, Kumaran N, Kalitzeos A, Weleber RG, Michaelides M.

Transl Vis Sci Technol. 2018 Nov 27;7(6):10. doi: 10.1167/tvst.7.6.10. eCollection 2018 Nov.

8.

The Progression of the Stargardt Disease Type 4 (ProgStar-4) Study: Design and Baseline Characteristics (ProgStar-4 Report No. 1).

Strauss RW, Muñoz B, Ahmed MI, Bittencourt M, Schönbach EM, Michaelides M, Birch D, Zrenner E, Ervin AM, Charbel Issa P, Kong J, Wolfson Y, Shah M, Bagheri S, West S, Scholl HPN; for the ProgStar-4 Study Group.

Ophthalmic Res. 2018;60(3):185-194. doi: 10.1159/000491791. Epub 2018 Aug 15.

PMID:
30110705
9.

Scotopic Microperimetric Assessment of Rod Function in Stargardt Disease (SMART) Study: Design and Baseline Characteristics (Report No. 1).

Strauss RW, Kong X, Bittencourt MG, Ho A, Jha A, Schönbach EM, Ahmed MI, Muñoz B, Ervin AM, Michaelides M, Birch DG, Sahel JA, Sunness JS, Zrenner E, Bagheri S, Ip M, Sadda S, West S, Scholl HPN; for the SMART Study Group.

Ophthalmic Res. 2019;61(1):36-43. doi: 10.1159/000488711. Epub 2018 Jun 25.

PMID:
29940588
10.

Detailed genetic characteristics of an international large cohort of patients with Stargardt disease: ProgStar study report 8.

Fujinami K, Strauss RW, Chiang JP, Audo IS, Bernstein PS, Birch DG, Bomotti SM, Cideciyan AV, Ervin AM, Marino MJ, Sahel JA, Mohand-Said S, Sunness JS, Traboulsi EI, West S, Wojciechowski R, Zrenner E, Michaelides M, Scholl HPN; ProgStar Study Group; On behalf of the ProgStar Study Group.

Br J Ophthalmol. 2019 Mar;103(3):390-397. doi: 10.1136/bjophthalmol-2018-312064. Epub 2018 Jun 20.

11.

Visual Acuity Change Over 24 Months and Its Association With Foveal Phenotype and Genotype in Individuals With Stargardt Disease: ProgStar Study Report No. 10.

Kong X, Fujinami K, Strauss RW, Munoz B, West SK, Cideciyan AV, Michaelides M, Ahmed M, Ervin AM, Schönbach E, Cheetham JK, Scholl HPN; ProgStar Study Group.

JAMA Ophthalmol. 2018 Aug 1;136(8):920-928. doi: 10.1001/jamaophthalmol.2018.2198.

12.

Longitudinal Changes of Fixation Location and Stability Within 12 Months in Stargardt Disease: ProgStar Report No. 12.

Schönbach EM, Strauss RW, Kong X, Muñoz B, Ibrahim MA, Sunness JS, Birch DG, Hahn GA, Nasser F, Zrenner E, Sadda SR, West SK, Scholl HPN; ProgStar Study Group.

Am J Ophthalmol. 2018 Sep;193:54-61. doi: 10.1016/j.ajo.2018.06.003. Epub 2018 Jun 8.

PMID:
29890160
13.

Progression of Stargardt Disease as Determined by Fundus Autofluorescence in the Retrospective Progression of Stargardt Disease Study (ProgStar Report No. 9).

Strauss RW, Muñoz B, Ho A, Jha A, Michaelides M, Cideciyan AV, Audo I, Birch DG, Hariri AH, Nittala MG, Sadda S, West S, Scholl HPN; ProgStar Study Group.

JAMA Ophthalmol. 2017 Nov 1;135(11):1232-1241. doi: 10.1001/jamaophthalmol.2017.4152.

14.

Metrics and Acquisition Modes for Fixation Stability as a Visual Function Biomarker.

Schönbach EM, Ibrahim MA, Kong X, Strauss RW, Muñoz B, Birch DG, Sunness JS, West SK, Scholl HPN.

Invest Ophthalmol Vis Sci. 2017 May 1;58(6):BIO268-BIO276. doi: 10.1167/iovs.17-21710.

PMID:
28973313
15.

Visual Acuity Change over 12 Months in the Prospective Progression of Atrophy Secondary to Stargardt Disease (ProgStar) Study: ProgStar Report Number 6.

Kong X, Strauss RW, Cideciyan AV, Michaelides M, Sahel JA, Munoz B, Ahmed M, Ervin AM, West SK, Cheetham JK, Scholl HPN; ProgStar Study Group.

Ophthalmology. 2017 Nov;124(11):1640-1651. doi: 10.1016/j.ophtha.2017.04.026. Epub 2017 May 23.

PMID:
28549516
16.

Incidence of Atrophic Lesions in Stargardt Disease in the Progression of Atrophy Secondary to Stargardt Disease (ProgStar) Study: Report No. 5.

Strauss RW, Muñoz B, Ho A, Jha A, Michaelides M, Mohand-Said S, Cideciyan AV, Birch D, Hariri AH, Nittala MG, Sadda S, Scholl HPN; ProgStar Study Group.

JAMA Ophthalmol. 2017 Jul 1;135(7):687-695. doi: 10.1001/jamaophthalmol.2017.1121.

17.

Macular Sensitivity Measured With Microperimetry in Stargardt Disease in the Progression of Atrophy Secondary to Stargardt Disease (ProgStar) Study: Report No. 7.

Schönbach EM, Wolfson Y, Strauss RW, Ibrahim MA, Kong X, Muñoz B, Birch DG, Cideciyan AV, Hahn GA, Nittala M, Sunness JS, Sadda SR, West SK, Scholl HPN; ProgStar Study Group.

JAMA Ophthalmol. 2017 Jul 1;135(7):696-703. doi: 10.1001/jamaophthalmol.2017.1162.

18.

The Core Competencies for General Orthopaedic Surgeons.

Kellam JF, Archibald D, Barber JW, Christian EP, D'Ascoli RJ, Haynes RJ, Hecht SS, Hurwitz SR, Kellam JF, McLaren AC, Peabody TD, Southworth SR, Strauss RW, Wadey VM.

J Bone Joint Surg Am. 2017 Jan 18;99(2):175-181. doi: 10.2106/JBJS.16.00761.

PMID:
28099309
19.

Progression of Visual Acuity and Fundus Autofluorescence in Recent-Onset Stargardt Disease: ProgStar Study Report #4.

Kong X, West SK, Strauss RW, Munoz B, Cideciyan AV, Michaelides M, Ho A, Ahmed M, Schönbach EM, Cheetham JK, Ervin AM, Scholl HPN; ProgStar study group.

Ophthalmol Retina. 2017 Nov - Dec;1(6):514-523. doi: 10.1016/j.oret.2017.02.008. Epub 2017 Apr 28.

PMID:
31047445
20.

Fixation Location and Stability Using the MP-1 Microperimeter in Stargardt Disease: ProgStar Report No. 3.

Schönbach EM, Ibrahim MA, Strauss RW, Birch DG, Cideciyan AV, Hahn GA, Ho A, Kong X, Nasser F, Sunness JS, Zrenner E, Sadda SR, West SK, Scholl HPN; Progression of Stargardt Disease Study Group.

Ophthalmol Retina. 2017 Jan - Feb;1(1):68-76. doi: 10.1016/j.oret.2016.08.009. Epub 2016 Oct 31.

PMID:
31047397
21.

Emerging therapies for inherited retinal degeneration.

Scholl HP, Strauss RW, Singh MS, Dalkara D, Roska B, Picaud S, Sahel JA.

Sci Transl Med. 2016 Dec 7;8(368):368rv6. Review.

PMID:
27928030
22.

Stargardt disease: clinical features, molecular genetics, animal models and therapeutic options.

Tanna P, Strauss RW, Fujinami K, Michaelides M.

Br J Ophthalmol. 2017 Jan;101(1):25-30. doi: 10.1136/bjophthalmol-2016-308823. Epub 2016 Aug 4. Review.

23.

Initial Validity Analysis of the American Board of Emergency Medicine Enhanced Oral Examination.

Kowalenko T, Heller BN, Strauss RW, Counselman FL, Mallory MN, Joldersma KB, Coombs AB, Harvey AL, Reisdorff EJ.

Acad Emerg Med. 2017 Jan;24(1):125-129. doi: 10.1111/acem.13068.

24.

Visual Acuity Loss and Associated Risk Factors in the Retrospective Progression of Stargardt Disease Study (ProgStar Report No. 2).

Kong X, Strauss RW, Michaelides M, Cideciyan AV, Sahel JA, Muñoz B, West S, Scholl HP; ProgStar Study Group.

Ophthalmology. 2016 Sep;123(9):1887-97. doi: 10.1016/j.ophtha.2016.05.027. Epub 2016 Jul 2.

PMID:
27378015
25.

Comparison of Short-Wavelength Reduced-Illuminance and Conventional Autofluorescence Imaging in Stargardt Macular Dystrophy.

Strauss RW, Muñoz B, Jha A, Ho A, Cideciyan AV, Kasilian ML, Wolfson Y, Sadda S, West S, Scholl HPN, Michaelides M.

Am J Ophthalmol. 2016 Aug;168:269-278. doi: 10.1016/j.ajo.2016.06.003. Epub 2016 Jun 11.

26.

Unilateral BEST1-Associated Retinopathy.

Arora R, Khan K, Kasilian ML, Strauss RW, Holder GE, Robson AG, Thompson DA, Moore AT, Michaelides M.

Am J Ophthalmol. 2016 Sep;169:24-32. doi: 10.1016/j.ajo.2016.05.024. Epub 2016 Jun 7.

27.

The Natural History of the Progression of Atrophy Secondary to Stargardt Disease (ProgStar) Studies: Design and Baseline Characteristics: ProgStar Report No. 1.

Strauss RW, Ho A, Muñoz B, Cideciyan AV, Sahel JA, Sunness JS, Birch DG, Bernstein PS, Michaelides M, Traboulsi EI, Zrenner E, Sadda S, Ervin AM, West S, Scholl HP; Progression of Stargardt Disease Study Group.

Ophthalmology. 2016 Apr;123(4):817-28. doi: 10.1016/j.ophtha.2015.12.009. Epub 2016 Jan 16.

PMID:
26786511
28.

COMPARISON OF MANUAL AND SEMIAUTOMATED FUNDUS AUTOFLUORESCENCE ANALYSIS OF MACULAR ATROPHY IN STARGARDT DISEASE PHENOTYPE.

Kuehlewein L, Hariri AH, Ho A, Dustin L, Wolfson Y, Strauss RW, Scholl HP, Sadda SR.

Retina. 2016 Jun;36(6):1216-21. doi: 10.1097/IAE.0000000000000870.

PMID:
26583307
29.

Assessment of estimated retinal atrophy progression in Stargardt macular dystrophy using spectral-domain optical coherence tomography.

Strauss RW, Muñoz B, Wolfson Y, Sophie R, Fletcher E, Bittencourt MG, Scholl HP.

Br J Ophthalmol. 2016 Jul;100(7):956-962. doi: 10.1136/bjophthalmol-2015-307035. Epub 2015 Nov 14.

30.

Evidence of macular pigment in the central macula in albinism.

Wolfson Y, Fletcher E, Strauss RW, Scholl HPN.

Exp Eye Res. 2016 Apr;145:468-471. doi: 10.1016/j.exer.2015.10.006. Epub 2015 Oct 22.

PMID:
26474496
31.

Retinal Architecture in ​RGS9- and ​R9AP-Associated Retinal Dysfunction (Bradyopsia).

Strauss RW, Dubis AM, Cooper RF, Ba-Abbad R, Moore AT, Webster AR, Dubra A, Carroll J, Michaelides M.

Am J Ophthalmol. 2015 Dec;160(6):1269-1275.e1. doi: 10.1016/j.ajo.2015.08.032. Epub 2015 Sep 3.

32.

CRB1-Related Maculopathy With Cystoid Macular Edema.

Wolfson Y, Applegate CD, Strauss RW, Han IC, Scholl HP.

JAMA Ophthalmol. 2015 Nov;133(11):1357-60. doi: 10.1001/jamaophthalmol.2015.2814. No abstract available.

PMID:
26312378
33.

Is There Excess Oxidative Stress and Damage in Eyes of Patients with Retinitis Pigmentosa?

Campochiaro PA, Strauss RW, Lu L, Hafiz G, Wolfson Y, Shah SM, Sophie R, Mir TA, Scholl HP.

Antioxid Redox Signal. 2015 Sep 1;23(7):643-8. doi: 10.1089/ars.2015.6327. Epub 2015 Apr 30.

34.

Intravitreal ranibizumab versus isovolemic hemodilution in the treatment of macular edema secondary to central retinal vein occlusion: twelve-month results of a prospective, randomized, multicenter trial.

Kreutzer TC, Wolf A, Dirisamer M, Strauss RW, Foerster P, Feltgen N, Pielen A, Hattenbach LO, Kampik A, Priglinger SG.

Ophthalmologica. 2015;233(1):8-17. doi: 10.1159/000369566. Epub 2014 Dec 10.

PMID:
25502833
35.

Quantification of contrast recognizability in sequential epiretinal membrane removal and internal limiting membrane peeling in trypan blue-assisted macular surgery.

Henrich PB, Priglinger SG, Haritoglou C, Schumann RG, Strauss RW, Schneider U, Josifova T, Cattin PC.

Retina. 2013 Apr;33(4):818-24. doi: 10.1097/IAE.0b013e318271f250.

PMID:
23400078
36.

Contrast recognizability during brilliant blue G - and heavier-than-water brilliant blue G-assisted chromovitrectomy: a quantitative analysis.

Henrich PB, Valmaggia C, Lang C, Priglinger SG, Haritoglou C, Strauss RW, Cattin PC.

Acta Ophthalmol. 2013 Mar;91(2):e120-4. doi: 10.1111/aos.12005. Epub 2012 Nov 20.

37.

Nanoscale topographic and biomechanical studies of the human internal limiting membrane.

Henrich PB, Monnier CA, Halfter W, Haritoglou C, Strauss RW, Lim RY, Loparic M.

Invest Ophthalmol Vis Sci. 2012 Jun 29;53(6):2561-70. doi: 10.1167/iovs.11-8502.

PMID:
22410559
38.

Changes in intraocular lens surface roughness during cataract surgery assessed by atomic force microscopy.

Strauss RW, Hochleitner ME, Gsenger W, Alge-Priglinger C, Faschinger CW, Henrich PB, Wedrich A, Priglinger SG, Schilcher K.

J Cataract Refract Surg. 2012 Jan;38(1):146-54. doi: 10.1016/j.jcrs.2011.07.028. Epub 2011 Nov 4.

PMID:
22055075
39.

[Static retinal vessel analysis in acute blood pressure increase].

Strauss RW, Lüdtke U, Kampik A, Neubauer AS.

Klin Monbl Augenheilkd. 2011 Jun;228(6):544-9. doi: 10.1055/s-0029-1245607. Epub 2011 Mar 25. German.

PMID:
21442571
40.

Quantification of Contrast Recognizability during Brilliant Blue G- and Indocyanine Green-Assisted Chromovitrectomy.

Henrich PB, Priglinger SG, Haritoglou C, Josifova T, Ferreira PR, Strauss RW, Flammer J, Cattin PC.

Invest Ophthalmol Vis Sci. 2011 Jun 17;52(7):4345-9. doi: 10.1167/iovs.10-6972.

PMID:
21372008
41.

Negative regulation of RPE cell attachment by carbohydrate-dependent cell surface binding of galectin-3 and inhibition of the ERK-MAPK pathway.

Alge-Priglinger CS, André S, Schoeffl H, Kampik A, Strauss RW, Kernt M, Gabius HJ, Priglinger SG.

Biochimie. 2011 Mar;93(3):477-88. doi: 10.1016/j.biochi.2010.10.021. Epub 2010 Nov 20.

PMID:
21094672
42.

[Detection of amlyogenic risk factors with the vision screener S 04].

Strauss RW, Ehrt O.

Klin Monbl Augenheilkd. 2010 Oct;227(10):798-803. doi: 10.1055/s-0029-1245784. Epub 2010 Oct 20. German.

PMID:
20963683
43.

Capsular tension ring-based in vitro capsule opacification model.

Burger J, Kreutzer T, Alge CS, Strauss RW, Eibl K, Haritoglou C, Neubauer AS, Kampik A, Priglinger SG.

J Cataract Refract Surg. 2008 Jul;34(7):1167-72. doi: 10.1016/j.jcrs.2008.03.040.

PMID:
18571087
44.

[Topographic, 3D and Quantitative analysis of autofluorescence in dry, age-related macular degeneration].

Strauss RW, Kampik A, Neubauer AS.

Klin Monbl Augenheilkd. 2007 Dec;224(12):927-31. doi: 10.1055/s-2007-963743. German.

PMID:
18260056
45.

Intravitreal bevacizumab injections for treatment of central retinal vein occlusion: six-month results of a prospective trial.

Priglinger SG, Wolf AH, Kreutzer TC, Kook D, Hofer A, Strauss RW, Alge CS, Kunze C, Haritoglou C, Kampik A.

Retina. 2007 Oct;27(8):1004-12.

PMID:
18040236
46.

Image quality characteristics of a novel colour scanning digital ophthalmoscope (SDO) compared with fundus photography.

Strauss RW, Krieglstein TR, Priglinger SG, Reis W, Ulbig MW, Kampik A, Neubauer AS.

Ophthalmic Physiol Opt. 2007 Nov;27(6):611-8.

PMID:
17956367
47.

Fluorescein angiography compared to three-dimensional measurements by the retinal thickness analyzer in classic choroidal neovascularization.

Strauss RW, Rombold F, Kampik A, Neubauer AS.

Ophthalmic Res. 2007;39(2):98-102. Epub 2007 Feb 2.

PMID:
17284936
48.

[Artifacts in optical coherence tomography (OCT) imaging of the retina].

Strauss RW, Scholz F, Ulbig MW, Kampik A, Neubauer AS.

Klin Monbl Augenheilkd. 2007 Jan;224(1):47-51. German.

PMID:
17260319
49.

Persistent serous retinal detachment after radial optic neurotomy.

Strauss RW, Priglinger SG, Alge CS, Grueterich M, Haritoglou C.

Clin Exp Ophthalmol. 2006 Sep-Oct;34(7):718-20.

PMID:
16970775
50.

Pulsed electron avalanche knife in vitreoretinal surgery.

Priglinger SG, Haritoglou C, Mueller A, Grueterich M, Strauss RW, Alge CS, Gandorfer A, Palanker D, Kampik A.

Retina. 2005 Oct-Nov;25(7):889-96.

PMID:
16205569

Supplemental Content

Loading ...
Support Center